Lactobacillus salivarius CRL 1328
- Reduced Gastrointestinal Symptoms
- Improved Immune Response
- Reduced Inflammatory Response
- Improved Gut Microbiome Composition
- Reduced Group B Streptococcus Colonization
- Improved Growth
- Enhanced Antiviral Response
- Reduced Campylobacter jejuni Inhibition
- Reduced Mastitis Risk
- Reduced Urogenital Pathogen Growth